Latest Commercial Strategy News

Page 2 of 17
Enlitic delivered its strongest quarter yet with A$5.1 million in contracts, including significant agreements with Penn Medicine, St. Jude Children’s Research Hospital, and Parkland Health, while improving cash flow and advancing its AI-powered Ensight platform.
Victor Sage
Victor Sage
29 Apr 2026
Entropy Neurodynamics has reported encouraging early clinical outcomes from its pioneering intravenous psilocin therapy for Binge Eating Disorder, alongside a patent grant that strengthens its intellectual property moat.
Ada Torres
Ada Torres
28 Apr 2026
Proteomics International is pivoting from research to disciplined commercial execution of its proteomics-based diagnostic tests, focusing on distributor partnerships and reimbursement pathways in Australia and the US.
Ada Torres
Ada Torres
28 Apr 2026
LTR Pharma has wrapped up recruitment for its SPONTAN Phase II pharmacokinetic study, with interim results expected soon to bolster FDA approval efforts. Meanwhile, US commercial talks for ROXUS advance cautiously under the FDA 503(a) personalised medicine pathway.
Ada Torres
Ada Torres
28 Apr 2026
Echo IQ has taken a major step in its US expansion by deploying its AI-powered EchoSolv AS software at Mount Sinai Health System, one of America’s leading cardiovascular centres. This marks a key milestone in integrating AI into routine cardiology workflows at scale.
Ada Torres
Ada Torres
28 Apr 2026
First Graphene has secured advanced graphene coatings technology through the AU$250,000 acquisition of Ionic Industries and Imagine Intelligent Materials, gaining immediate entry into lucrative geotextile and environmental infrastructure sectors.
Maxwell Dee
Maxwell Dee
28 Apr 2026
Biome Australia has taken a significant step in its innovation journey by filing a patent for its next generation probiotic strain BMB18, with a clinical trial set to begin in Q4 FY26 in partnership with La Trobe University.
Ada Torres
Ada Torres
27 Apr 2026
Imricor Medical Systems updates its SEC Form 10 with minor SEC-driven revisions as it pushes forward with FDA clearances and clinical trials, reporting a $25.3 million net loss in 2025 amid early-stage commercialisation.
Ada Torres
Ada Torres
27 Apr 2026
Rimfire Pacific Mining has confirmed significant gold and antimony mineralisation at its Windy Ridge prospect through resampling of diamond drill core dating back 40-50 years. The findings highlight a 600-metre mineralised corridor open at depth and near surface within the Broken Hill Base Metal Project.
Maxwell Dee
Maxwell Dee
24 Apr 2026
Mount Hope Mining (ASX:MHM) has completed Phases 1 and 2 drilling at its Mt Solitary gold project in NSW’s Cobar Basin, delivering high-grade intercepts including visible gold up to 52.5 g/t and defining an exploration target of 1.3-1.9 million tonnes at 1.0-1.35 g/t Au.
Maxwell Dee
Maxwell Dee
23 Apr 2026
Minrex Resources appoints Max Piirto as CEO to spearhead exploration and development across its newly acquired Serbian gold and copper assets following the Electrum merger.
Maxwell Dee
Maxwell Dee
22 Apr 2026
Orthocell has swiftly converted regulatory approval into clinical use with the first Remplir™ surgery completed in a US Department of Defense hospital, marking a key step in its US commercial expansion.
Ada Torres
Ada Torres
17 Apr 2026